Judith Dixon-Hughes

Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial

Jonathan Moss, Olívia Wu, Andrew Bodenham et al. · The Lancet · 2021 · 147 citations

Medicine, Oncology, Surgery +14

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Gillian A. Horne, Jon Stobo, Caroline Kelly et al. · Leukemia · 2020 · 77 citations · Full text

Medicine, Hematology, Pharmacology +16

Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation

Olívia Wu, Kathleen Boyd, Elaine McCartney et al. · British Journal of Cancer · 2016 · 48 citations · Full text

Pharmacy, Pharmacoeconomics, Surgery +17

Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study

Caoimhe Ryan, Hannah Hesselgreaves, Olívia Wu et al. · BMJ Open · 2019 · 39 citations · Full text

Medicine, Oncology, Surgery +16

Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer

Robert J. Jones, Syed A. Hussain, Andrew Protheroe et al. · Journal of Clinical Oncology · 2017 · 30 citations · Full text

Medicine, Oncology, Pharmacology +8